<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Westminster_UK_markdown-test skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Westminster UK/markdown-test</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="WordSection1"><P class="MsoTitle"><SPAN lang="EN-US">Biomaterials Group Project</SPAN></P><P class="MsoNormal"><SPAN lang="EN-US"> </SPAN></P><TABLE class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none"><TBODY><TR><TD width="156" valign="top" style="width:155.8pt;border:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><SPAN lang="EN-US">NAME</SPAN></P></TD><TD width="156" valign="top" style="width:155.85pt;border:solid windowtext 1.0pt; border-left:none;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><SPAN lang="EN-US">INITIALS</SPAN></P></TD><TD width="156" valign="top" style="width:155.85pt;border:solid windowtext 1.0pt; border-left:none;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><SPAN lang="EN-US">STUDENT NUMBER</SPAN></P></TD></TR><TR><TD width="156" valign="top" style="width:155.8pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><SPAN lang="EN-US">Oran Maguire</SPAN></P></TD><TD width="156" valign="top" style="width:155.85pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><SPAN lang="EN-US">OM</SPAN></P></TD><TD width="156" valign="top" style="width:155.85pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><SPAN lang="EN-US"> </SPAN></P></TD></TR><TR><TD width="156" valign="top" style="width:155.8pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><SPAN lang="EN-US">Mohammed Ali Amin Banani</SPAN></P></TD><TD width="156" valign="top" style="width:155.85pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><SPAN lang="EN-US">MB</SPAN></P></TD><TD width="156" valign="top" style="width:155.85pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><SPAN lang="EN-US"> </SPAN></P></TD></TR><TR><TD width="156" valign="top" style="width:155.8pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><SPAN lang="EN-US">Rebecca Varley</SPAN></P></TD><TD width="156" valign="top" style="width:155.85pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><SPAN lang="EN-US">RV</SPAN></P></TD><TD width="156" valign="top" style="width:155.85pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><SPAN lang="EN-US"> </SPAN></P></TD></TR><TR><TD width="156" valign="top" style="width:155.8pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><SPAN lang="EN-US">Komal Ramsahye</SPAN></P></TD><TD width="156" valign="top" style="width:155.85pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><SPAN lang="EN-US">KR</SPAN></P></TD><TD width="156" valign="top" style="width:155.85pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><SPAN lang="EN-US"> </SPAN></P></TD></TR></TBODY></TABLE><P class="MsoTitle"><SPAN lang="EN-US">SPION-carrying polymersomes in cancer
theranostics. </SPAN></P><P class="MsoNormal"><SPAN lang="EN-US">*** We envisage specifying our study to a
cancer type or a class of class of cancer types.</SPAN></P><DIV id="toc" class="toc"><DIV id="toctitle"><H2>Contents</H2></DIV><UL><LI class="toclevel-1"><A href="#Introduction"><SPAN class="tocnumber">1</SPAN><SPAN class="toctext"><SPAN>Introduction</SPAN></SPAN></A></LI><LI class="toclevel-2"><A href="#Definition_of_SPIONs"><SPAN class="tocnumber">1.1</SPAN><SPAN class="toctext"><SPAN>Definition of SPIONs</SPAN></SPAN></A></LI><LI class="toclevel-2"><A href="#Definition_of_polymersomes"><SPAN class="tocnumber">1.2</SPAN><SPAN class="toctext"><SPAN>Definition of polymersomes</SPAN></SPAN></A></LI><LI class="toclevel-2"><A href="#Generic_treatment_in_.28.3Fclass_of.3F.29_cancer_theranostics."><SPAN class="tocnumber">1.3</SPAN><SPAN class="toctext"><SPAN>Generic treatment in (?class of?) cancer theranostics.</SPAN></SPAN></A></LI><LI class="toclevel-2"><A href="#Clinical_Benefits_of_SPION-loaded_polymersome_theranostics"><SPAN class="tocnumber">1.4</SPAN><SPAN class="toctext"><SPAN>Clinical Benefits of SPION-loaded polymersome theranostics</SPAN></SPAN></A></LI></UL><LI class="toclevel-1"><A href="#Superparamagnetic_Iron_Oxide_Nanoparticles"><SPAN class="tocnumber">2</SPAN><SPAN class="toctext"><SPAN>Superparamagnetic Iron Oxide Nanoparticles</SPAN></SPAN></A></LI><LI class="toclevel-2"><A href="#Clinically_approved_SPIONs"><SPAN class="tocnumber">2.1</SPAN><SPAN class="toctext"><SPAN>Clinically approved SPIONs</SPAN></SPAN></A></LI><LI class="toclevel-2"><A href="#SPIONs_with_enhanced_magnetism"><SPAN class="tocnumber">2.2</SPAN><SPAN class="toctext"><SPAN>SPIONs with enhanced magnetism</SPAN></SPAN></A></LI><LI class="toclevel-1"><A href="#SPION-Loaded_Polymersome_Material_Characteristisation"><SPAN class="tocnumber">3</SPAN><SPAN class="toctext"><SPAN>SPION-Loaded Polymersome Material Characteristisation</SPAN></SPAN></A></LI><LI class="toclevel-2"><A href="#Structure"><SPAN class="tocnumber">3.1</SPAN><SPAN class="toctext"><SPAN>Structure</SPAN></SPAN></A></LI><LI class="toclevel-2"><A href="#Polymer_Characteristics"><SPAN class="tocnumber">3.2</SPAN><SPAN class="toctext"><SPAN>Polymer Characteristics</SPAN></SPAN></A></LI><LI class="toclevel-2"><A href="#Figure:_Polymersome_structures_in_comparison"><SPAN class="tocnumber">3.3</SPAN><SPAN class="toctext"><B><SPAN>Figure: Polymersome structures in comparison</SPAN></B></SPAN></A></LI><LI class="toclevel-1"><A href="#Production_Methods"><SPAN class="tocnumber">4</SPAN><SPAN class="toctext"><SPAN>Production Methods </SPAN></SPAN></A></LI><LI class="toclevel-2"><A href="#Consistency_of_magnetic_properties_vs_in_situ_production."><SPAN class="tocnumber">4.1</SPAN><SPAN class="toctext"><SPAN>Consistency of magnetic properties vs in situ production. </SPAN></SPAN></A></LI><LI class="toclevel-2"><A href="#Table:_Production_methods_vs_function"><SPAN class="tocnumber">4.2</SPAN><SPAN class="toctext"><B><SPAN>Table: Production methods vs function</SPAN></B></SPAN></A></LI><LI class="toclevel-1"><A href="#Cell_Interactions_in_vitro."><SPAN class="tocnumber">5</SPAN><SPAN class="toctext"><SPAN>Cell Interactions <I>in vitro</I>.</SPAN></SPAN></A></LI><LI class="toclevel-2"><A href="#Cell_Targeting"><SPAN class="tocnumber">5.1</SPAN><SPAN class="toctext"><SPAN>Cell Targeting</SPAN></SPAN></A></LI><LI class="toclevel-2"><A href="#Degradation"><SPAN class="tocnumber">5.2</SPAN><SPAN class="toctext"><SPAN>Degradation </SPAN></SPAN></A></LI><LI class="toclevel-2"><A href="#Toxicity_and_compatibility"><SPAN class="tocnumber">5.3</SPAN><SPAN class="toctext"><SPAN>Toxicity and compatibility</SPAN></SPAN></A></LI><LI class="toclevel-1"><A href="#Cell_interactions_in_vivo."><SPAN class="tocnumber">6</SPAN><SPAN class="toctext"><SPAN>Cell interactions <I>in vivo</I>.</SPAN></SPAN></A></LI><LI class="toclevel-2"><A href="#Imaging"><SPAN class="tocnumber">6.1</SPAN><SPAN class="toctext"><SPAN>Imaging</SPAN></SPAN></A></LI><LI class="toclevel-2"><A href="#Delivery_to_target_tissue"><SPAN class="tocnumber">6.2</SPAN><SPAN class="toctext"><SPAN>Delivery to target tissue</SPAN></SPAN></A></LI><LI class="toclevel-2"><A href="#Heat_therapy"><SPAN class="tocnumber">6.3</SPAN><SPAN class="toctext"><SPAN>Heat therapy</SPAN></SPAN></A></LI><LI class="toclevel-2"><A href="#Table:_Smart_Drug_delivery"><SPAN class="tocnumber">6.4</SPAN><SPAN class="toctext"><B><SPAN>Table: Smart Drug delivery</SPAN></B></SPAN></A></LI><LI class="toclevel-1"><A href="#Summary"><SPAN class="tocnumber">7</SPAN><SPAN class="toctext"><SPAN>Summary</SPAN></SPAN></A></LI><LI class="toclevel-2"><A href="#Future_Clinical_Applications"><SPAN class="tocnumber">7.1</SPAN><SPAN class="toctext"><SPAN>Future Clinical Applications</SPAN></SPAN></A></LI><LI class="toclevel-3"><A href="#Imaging_2"><SPAN class="tocnumber">7.1.1</SPAN><SPAN class="toctext"><SPAN>Imaging</SPAN></SPAN></A></LI><LI class="toclevel-3"><A href="#Smart_Drug_release"><SPAN class="tocnumber">7.1.2</SPAN><SPAN class="toctext"><SPAN>Smart Drug release</SPAN></SPAN></A></LI><LI class="toclevel-3"><A href="#Heat_therapy_2"><SPAN class="tocnumber">7.1.3</SPAN><SPAN class="toctext"><SPAN>Heat therapy</SPAN></SPAN></A></LI><LI class="toclevel-2"><A href="#Commercialisation_and_limitations."><SPAN class="tocnumber">7.2</SPAN><SPAN class="toctext"><SPAN>Commercialisation and limitations.</SPAN></SPAN></A></LI><LI class="toclevel-1"><A href="#To_consider_with_SPION-loaded_polymersomes."><SPAN class="tocnumber">8</SPAN><SPAN class="toctext"><SPAN>To consider with SPION-loaded polymersomes.</SPAN></SPAN></A></LI></DIV><H1><SPAN class="mw-headline" id="Introduction"><SPAN lang="EN-US">Introduction</SPAN></SPAN></H1><H2><SPAN class="mw-headline" id="Definition_of_SPIONs"><SPAN lang="EN-US">Definition of SPIONs</SPAN></SPAN></H2><H2><SPAN class="mw-headline" id="Definition_of_polymersomes"><SPAN lang="EN-US">Definition of polymersomes</SPAN></SPAN></H2><H2><SPAN class="mw-headline" id="Generic_treatment_in_.28.3Fclass_of.3F.29_cancer_theranostics."><SPAN lang="EN-US">Generic treatment in (?class of?) cancer theranostics.</SPAN></SPAN></H2><H2><SPAN class="mw-headline" id="Clinical_Benefits_of_SPION-loaded_polymersome_theranostics"><SPAN lang="EN-US">Clinical Benefits of SPION-loaded polymersome theranostics</SPAN></SPAN></H2><H1><SPAN class="mw-headline" id="Superparamagnetic_Iron_Oxide_Nanoparticles"><SPAN lang="EN-US">Superparamagnetic Iron Oxide Nanoparticles</SPAN></SPAN></H1><H2><SPAN class="mw-headline" id="Clinically_approved_SPIONs"><SPAN lang="EN-US">Clinically approved SPIONs</SPAN></SPAN></H2><H2><SPAN class="mw-headline" id="SPIONs_with_enhanced_magnetism"><SPAN lang="EN-US">SPIONs with enhanced magnetism</SPAN></SPAN></H2><H1><SPAN class="mw-headline" id="SPION-Loaded_Polymersome_Material_Characteristisation"><SPAN lang="EN-US">SPION-Loaded Polymersome Material Characteristisation</SPAN></SPAN></H1><H2><SPAN class="mw-headline" id="Structure"><SPAN lang="EN-US">Structure</SPAN></SPAN></H2><H2><SPAN class="mw-headline" id="Polymer_Characteristics"><SPAN lang="EN-US">Polymer Characteristics</SPAN></SPAN></H2><H2><SPAN class="mw-headline" id="Figure:_Polymersome_structures_in_comparison"><B><SPAN lang="EN-US">Figure: Polymersome structures in comparison</SPAN></B></SPAN></H2><H1><SPAN class="mw-headline" id="Production_Methods"><SPAN lang="EN-US">Production Methods </SPAN></SPAN></H1><H2><SPAN class="mw-headline" id="Consistency_of_magnetic_properties_vs_in_situ_production."><SPAN lang="EN-US">Consistency of magnetic properties vs in situ production. </SPAN></SPAN></H2><H2><SPAN class="mw-headline" id="Table:_Production_methods_vs_function"><B><SPAN lang="EN-US">Table: Production methods vs function</SPAN></B></SPAN></H2><H1><SPAN class="mw-headline" id="Cell_Interactions_in_vitro."><SPAN lang="EN-US">Cell Interactions <I>in vitro</I>.</SPAN></SPAN></H1><H2><SPAN class="mw-headline" id="Cell_Targeting"><SPAN lang="EN-US">Cell Targeting</SPAN></SPAN></H2><H2><SPAN class="mw-headline" id="Degradation"><SPAN lang="EN-US">Degradation </SPAN></SPAN></H2><H2><SPAN class="mw-headline" id="Toxicity_and_compatibility"><SPAN lang="EN-US">Toxicity and compatibility</SPAN></SPAN></H2><H1><SPAN class="mw-headline" id="Cell_interactions_in_vivo."><SPAN lang="EN-US">Cell interactions <I>in vivo</I>.</SPAN></SPAN></H1><H2><SPAN class="mw-headline" id="Imaging"><SPAN lang="EN-US">Imaging</SPAN></SPAN></H2><H2><SPAN class="mw-headline" id="Delivery_to_target_tissue"><SPAN lang="EN-US">Delivery to target tissue</SPAN></SPAN></H2><H2><SPAN class="mw-headline" id="Heat_therapy"><SPAN lang="EN-US">Heat therapy</SPAN></SPAN></H2><H2><SPAN class="mw-headline" id="Table:_Smart_Drug_delivery"><B><SPAN lang="EN-US">Table: Smart Drug delivery</SPAN></B></SPAN></H2><H1><SPAN class="mw-headline" id="Summary"><SPAN lang="EN-US">Summary</SPAN></SPAN></H1><H2><SPAN class="mw-headline" id="Future_Clinical_Applications"><SPAN lang="EN-US">Future Clinical Applications</SPAN></SPAN></H2><H3><SPAN class="mw-headline" id="Imaging_2"><SPAN lang="EN-US">Imaging</SPAN></SPAN></H3><H3><SPAN class="mw-headline" id="Smart_Drug_release"><SPAN lang="EN-US">Smart Drug release</SPAN></SPAN></H3><H3><SPAN class="mw-headline" id="Heat_therapy_2"><SPAN lang="EN-US">Heat therapy</SPAN></SPAN></H3><H2><SPAN class="mw-headline" id="Commercialisation_and_limitations."><SPAN lang="EN-US">Commercialisation and limitations.</SPAN></SPAN></H2><P class="MsoNormal"><SPAN lang="EN-US"> </SPAN></P><H1><SPAN class="mw-headline" id="To_consider_with_SPION-loaded_polymersomes."><SPAN lang="EN-US">To consider with SPION-loaded polymersomes.</SPAN></SPAN></H1><P class="MsoNormal"><SPAN lang="EN-US">Important Material Properties</SPAN></P><P class="MsoNormal"><SPAN lang="EN-US">Biomaterial Design Considerations.</SPAN></P><P class="MsoNormal"><SPAN lang="EN-US">Bio... inertness, resorbability,
bioactivity, functionalisation, (inflammation, immune response, toxicity)</SPAN></P><P class="MsoNormal"><SPAN lang="EN-US">Topography / Surface Chemistry of a
changeable structure? How to attach?</SPAN></P><P class="MsoNormal"><SPAN lang="EN-US">What are the adsorbtion / degradation
mechanisms for the polymers and NPs. Byproducts?</SPAN></P><P class="MsoNormal"><SPAN lang="EN-US">Micro polymersome properties vs Nano SPION
properties.</SPAN></P><P class="MsoNormal"><SPAN lang="EN-US">Cellular interaction (and
functionalisation?) wrt physical / chemical attributes and
biofunctionalisation? Surface patterning?</SPAN></P><P class="MsoNormal"><SPAN lang="EN-US"> </SPAN></P><P class="MsoNormal"><SPAN lang="EN-US"> </SPAN></P><P class="MsoNormal"><SPAN lang="EN-US"> </SPAN></P></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>